Literature DB >> 6086291

The effect of dexamethasone on parathyroid hormone stimulation of adenylate cyclase in ROS 17/2.8 cells.

S B Rodan, M K Fischer, J J Egan, P M Epstein, G A Rodan.   

Abstract

Treatment of ROS 17/2.8 osteosarcoma-derived cells with dexamethasone potentiates the PTH stimulation of adenylate cyclase in these cells, yielding a detectable response to as little as 10 pM PTH. Isoproterenol stimulation was also enhanced. The dexamethasone effect is first apparent at 12 h and increases with time of treatment. The apparent EC50 for dexamethasone is 3 nM. Hydrocortisone and corticosterone act similarly to dexamethasone, but require 30-fold higher concentrations. Dexamethasone treatment produces no change in high affinity phosphodiesterase activity. Glucocorticoid-potentiating effects are much more pronounced in whole cells than in broken cells and do not influence forskolin stimulation. Particulate fractions of dexamethasone-treated cells have higher adenylate cyclase specific activity, but are stimulated by guanyl-5'-yl imidodiphosphate to the same extent as control cells. These findings suggest that the glucocorticoids potentiate hormone responsiveness through promotion of hormone receptor-adenylate cyclase coupling by a mechanism dependent on cellular integrity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086291     DOI: 10.1210/endo-115-3-951

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106.

Authors:  T K Gray; T C Flynn; K M Gray; L M Nabell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

2.  Partial characterization of rat marrow stromal cells.

Authors:  D J Simmons; P Seitz; L Kidder; G L Klein; M Waeltz; C M Gundberg; C Tabuchi; C Yang; R W Zhang
Journal:  Calcif Tissue Int       Date:  1991-05       Impact factor: 4.333

3.  Increase of adenylate cyclase catalytic-unit activity by dexamethasone in rat osteoblast-like cells.

Authors:  R Rizzoli; V von Tscharner; H Fleisch
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

4.  Humoral hypercalcemia of malignancy. Release of a prostaglandin-stimulating bone-resorbing factor in vitro by human transitional-cell carcinoma cells.

Authors:  F R Bringhurst; B E Bierer; F Godeau; N Neyhard; V Varner; G V Segre
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

5.  Dexamethasone enhances the effects of parathyroid hormone on human periodontal ligament cells in vitro.

Authors:  R M Nohutcu; M J Somerman; L K McCauley
Journal:  Calcif Tissue Int       Date:  1995-06       Impact factor: 4.333

6.  Human bone marrow stromal cells express an osteoblastic phenotype in culture.

Authors:  J Vilamitjana-Amedee; R Bareille; F Rouais; A I Caplan; M F Harmand
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-09       Impact factor: 2.416

7.  The effect of long- and short-term corticosteroids on plasma calcitonin and parathyroid hormone levels.

Authors:  A T Hattersley; K Meeran; J Burrin; P Hill; R Shiner; H K Ibbertson
Journal:  Calcif Tissue Int       Date:  1994-03       Impact factor: 4.333

8.  Comparison of postreceptor effects of 1-34 human hypercalcemia factor and 1-34 human parathyroid hormone in rat osteosarcoma cells.

Authors:  S B Rodan; M Noda; G Wesolowski; M Rosenblatt; G A Rodan
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.